Calidi Biotherapeutics, Inc. (CLDI)

SEC filing

Calidi Biotherapeutics, Inc.

CLDI · CIK 1855485

4 · Aug 19, 2026 · Chief Scientific Officer Fernandez Santidrian Antonio was granted 16K Stock Options (right to buy)

Chief Scientific Officer Fernandez Santidrian Antonio was granted 16K Stock Options (right to buy)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

ex24.htm

ex24.htmSEC.gov

Graphics and non-inline formats (not embedded below).